Metharow 50 Mg 50 Tablets CrowxLabs USA

Product Overview

Metharow 50 mg 50 Tablets CrowxLabs USA delivers methandienone (C20H28O2), the 17α-methylated testosterone derivative anabolic steroid exhibiting potent oral bioavailability, at high 50 mg potency per tablet. Each tamper-evident unit contains 50 tablets with embedded security holograms enabling instant authenticity confirmation via crowxlabs.net.​

CrowxLabs USA’s GMP-standard multi-continental production combined with domestic warehousing eliminates customs exposure while published analytics validate pharmaceutical-grade purity distinguishing from underground tablet presses. This premium high-strength configuration serves CIII-authorized specialist platforms where institutional buyers require batch traceability matching DEA-compliant inventory protocols.

Metharow positions exclusively within verified performance ecosystems targeting knowledgeable adult consumers familiar with Schedule III methandienone formulations rather than general supplement categories.

Brand & Manufacturer Information

CrowxLabs USA manufactures institutional-grade anabolic steroids including Metharow through U.S./EU/Asia GMP facilities serving domestic resellers requiring controlled substance compliance. Proprietary 12-digit hologram verification prevents counterfeiting prevalent in Dianabol-class products.​

The 50 mg strength maintains catalog continuity alongside Crowx Oxarow/Winsrow while scannable coding supports DEA Form 222 workflows distinguishing legitimate institutional supply from powder-converted alternatives common in non-verified channels.

Active Compound Information

Metharow contains methandienone (17α-methyl-Δ¹-testosterone), C1,2 double-bond modified androgen featuring 17α-alkylation preventing first-pass metabolism while enabling rapid anabolic signaling. Molecular weight 300.44; Schedule III classification reflects hepatotoxicity profile and high anabolic potency (~200:50-100 rating).​

50 mg represents performance-grade escalation from discontinued 5-10 mg prescription formats while maintaining identical Δ¹ unsaturation distinguishing from standard methandrostenolone. WADA S1 prohibited; regulated 21 CFR 1308.13. Listing identifies specifications exclusively.

Product Specifications

• Product name: Metharow 50 mg 50 Tablets CrowxLabs USA

• Brand/manufacturer: CrowxLabs USA​

• Active compound: Methandienone (C20H28O2)

• Strength: 50 mg per tablet​

• Quantity per pack: 50 tablets

• Dosage form: Oral tablets

• Category: Schedule III anabolic steroid

• Security: Hologram + 12-digit verification​

• Primary packaging: Tamper-evident bottle

• Label elements: 50 mg declaration, hologram code​

Quality Control & Testing Standards

50 mg methandienone demands enhanced hepatoprotectant stability, potency assay (90-110% claim), and uniformity testing beyond low-dose standards. CrowxLabs publishes crowxlabs.net certificates verifying C20H28O2 identity, content uniformity, and Schedule III-compliant excipients excluding contraindicated fillers.​

Hologram system prevents counterfeiting; GMP multi-facility production maintains consistency distinguishing from under-dosed presses prevalent across Dianabol-class underground markets.

Intended Use & Market Positioning

Metharow 50 mg serves CIII-authorized performance researchers managing high-dosage methandienone inventories exclusively. 50 mg strength excludes crossover positioning within premium verified catalogs. Zero protocols represented.

Packaging, Storage & Handling

Tamper-evident bottles protect light-sensitive methandienone; verification activates post-receipt at crowxlabs.net. Controlled 20-25°C locked per DEA; facilities maintain lot-specific inventory logs.​

Purchasing & Availability Information

Domestic platforms provide encrypted CIII checkout, 21+ verification, Priority discreet USPS from Crowx warehouses. “Metharow 50” SKU differentiates institutional product; supports repeat compliant procurement.

Legal & Regulatory Disclaimer

Methandienone constitutes DEA Schedule III; non-medical distribution/possession violates 21 USC §812. Buyer assumes Form 222 compliance; zero medical claims/protocols provided.​